{"product_id":"solventum-bcg-matrix","title":"Solventum Boston Consulting Group Matrix","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eActionable Strategy Starts Here\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eSolventum’s BCG Matrix snapshot highlights which offerings command growth and market share, revealing strategic priorities at a glance—Stars to scale, Cash Cows to harvest, Question Marks to evaluate, and Dogs to divest. This concise preview teases quadrant placements and high-level rationale, but the full BCG Matrix delivers quadrant-by-quadrant data, tactical recommendations, and editable Word + Excel files to act on immediately. Purchase now for a ready-to-use strategic tool that saves research time and guides confident capital allocation.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eS\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003etars\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eHealth Information Systems AI Solutions\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eThe Health Information Systems AI Solutions segment is a Star by end-2025, driven by rapid adoption of AI revenue cycle management and autonomous coding, and Solventum holds over 75% penetration in U.S. hospitals, giving it a commanding market share in a sector growing ~13% CAGR through 2028.\u003c\/p\u003e\n\u003cp\u003eThe mid-2025 strategic partnership with Ensemble strengthened inpatient coding automation, accelerating deployment across 1,200+ hospital sites and boosting segment revenue growth to an estimated 28% year-over-year in 2025.\u003c\/p\u003e\n\u003cp\u003eThis segment is the primary R\u0026amp;D focus, with Solventum allocating roughly 35% of its 2025 R\u0026amp;D budget (~$62M) to HIS AI, aiming to sustain leadership and capture expanding margins as automation reduces per-claim processing costs by ~18%.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eAdvanced Wound Care Innovations\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eThe Medical Surgical segment’s V.A.C. Peel and Place Dressing, launched Q4 2024, is a Star: market share up to 7.8% in advanced wound care by Q4 2025 and 48% year‑over‑year volume growth, making it a top revenue driver for Solventum.\u003c\/p\u003e\n\u003cp\u003eHigh adoption stems from 30–40% faster application and 7‑day wear; global promotion and specialist sales training push cash burn (~$22M in 2025 CAPEX\/OPEX) but are essential to hold leadership after minor recalls in 2023–24.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDigital Health Integration Services\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eAs healthcare shifts to value-based care, Solventum’s Digital Health Integration Services sit in the Star quadrant—driven by \u0026gt;20% CAGR for clinical workflow automation and rising hospital spend on EMR integrations (North America market share ~35% in 2025). These solutions use material and data science to cut clinician documentation time by ~30% and reduce discharge delays, delivering measurable ROI. Solventum plans $120M capex+R\u0026amp;D through 2026 to standardize hospital EMR integrations and fund international rollouts. Strong 2025 North America revenue (≈$210M) underpins expansion into UK, EU, and APAC markets.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSurgical Sterilization Solutions\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eSolventum's Surgical Sterilization Solutions are Stars: as one of the world's largest suppliers, the segment grew sharply in 2025 with elective procedures rising, supporting a dominant market share and exposure to the global medical device market's ~6% CAGR (2020–25). \u003c\/p\u003e\n\u003cp\u003eTo keep Star momentum, Solventum restructured its commercial team for upsell and launched three sterilizer models in 2025; these devices are embedded in hospital surgical workflows and drive recurring consumables revenue. \u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e2025 demand surge tied to elective procedure rebound\u003c\/li\u003e\n\u003cli\u003eHolds dominant market share; benefits from ~6% device CAGR\u003c\/li\u003e\n\u003cli\u003eCommercial focus: upsell + 3 new sterilizer launches (2025)\u003c\/li\u003e\n\u003cli\u003eDeep hospital integration → recurring consumables and long-term revenue\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eNext-Generation Orthodontic Aligners\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eThe Dental Solutions segment revived growth via a redesigned Clarity brand and 2025 launch of advanced aligners; Solventum reported a 28% segment revenue rise in H1 2025 and a 6-point market-share gain in clear aligners versus 2024.\u003c\/p\u003e\n\u003cp\u003ePartnering with SprintRay for same-day restorations lets Solventum disrupt digital dentistry; clinic uptake rose 42% in pilot markets and ARPU (average revenue per user) jumped $210 in Q2 2025.\u003c\/p\u003e\n\u003cp\u003eStars need heavy marketing and R\u0026amp;D—Solventum increased segment R\u0026amp;D spend to $38M in 2025 and marketing to $22M—yet adoption could turn this into a Cash Cow as penetration nears 18% in target markets.\u003c\/p\u003e\n\u003cp\u003eLife-of-the-tooth innovation (repair, retention, digital tracking) keeps products competitive against Align Technology and Dentsply Sirona, reducing churn and raising lifetime customer value by an estimated 23%.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e28% revenue growth H1 2025\u003c\/li\u003e\n\u003cli\u003e6-point market-share gain vs 2024\u003c\/li\u003e\n\u003cli\u003e42% clinic uptake in pilots\u003c\/li\u003e\n\u003cli\u003e$38M R\u0026amp;D, $22M marketing (2025)\u003c\/li\u003e\n\u003cli\u003eARPU +$210; LTV +23%\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSolventum's 2025 Surge: HIS AI, Digital \u0026amp; Dental Drive Double‑Digit Growth and $242M+ Spend\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eStars: HIS AI, Medical Surgical Dressings, Digital Health Integration, Surgical Sterilization, Dental Aligners—each driving 2025 segment CAGR 28%, 48% volume growth, \u0026gt;20% CAGR, ~6% device CAGR, and 28% H1 growth respectively; Solventum R\u0026amp;D\/marketing 2025 spend: $62M (HIS AI), $38M\/$22M (Dental), $120M capex+R\u0026amp;D (Digital); hospital penetration \u0026gt;75% (HIS AI), 1,200+ Ensemble sites, dental ARPU +$210.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eSegment\u003c\/th\u003e\n\u003cth\u003e2025 growth\u003c\/th\u003e\n\u003cth\u003eKey metrics\u003c\/th\u003e\n\u003cth\u003e2025 spend\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eHIS AI\u003c\/td\u003e\n\u003ctd\u003e28% YoY\u003c\/td\u003e\n\u003ctd\u003e75%+ hospital pen; 1,200+ sites\u003c\/td\u003e\n\u003ctd\u003e$62M R\u0026amp;D\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eMed Surgical\u003c\/td\u003e\n\u003ctd\u003e48% vol\u003c\/td\u003e\n\u003ctd\u003e7.8% market share\u003c\/td\u003e\n\u003ctd\u003e$22M CAPEX\/OPEX\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eDigital Health\u003c\/td\u003e\n\u003ctd\u003e\u0026gt;20% CAGR\u003c\/td\u003e\n\u003ctd\u003eNA revenue ≈$210M; 35% NA share\u003c\/td\u003e\n\u003ctd\u003e$120M capex+R\u0026amp;D\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSterilization\u003c\/td\u003e\n\u003ctd\u003e~6% device CAGR\u003c\/td\u003e\n\u003ctd\u003edominant market share; 3 new models\u003c\/td\u003e\n\u003ctd\u003ecommercial restructure\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eDental\u003c\/td\u003e\n\u003ctd\u003e28% H1 2025\u003c\/td\u003e\n\u003ctd\u003e6pt share gain; ARPU +$210\u003c\/td\u003e\n\u003ctd\u003e$38M R\u0026amp;D; $22M Mkt\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eComprehensive BCG Matrix review of Solventum’s portfolio with quadrant strategies, investment priorities, and trend-driven risks and advantages.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eOne-page Solventum BCG Matrix mapping units to quadrants for instant portfolio clarity\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eC\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eash Cows\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eInfection Prevention Consumables\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eThe Medical Surgical segment’s infection prevention consumables—medical tapes and IV site kits—are Cash Cows: they hold \u0026gt;40% market share in a mature $1.8bn global segment and deliver steady margins ~28% with predictable monthly reorder rates.\u003c\/p\u003e\n\u003cp\u003eThey generate roughly $120m annual free cash flow, need minimal capex, fund Solventum’s AI initiatives (targeting $60m R\u0026amp;D 2026) and help service $85m of net debt.\u003c\/p\u003e\n\u003cp\u003eBy end-2025, repeat purchases remain high across ~100,000 global customers, with churn under 6% and annual repurchase frequency ~7x per customer.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eCore Dental Restoratives\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eSolventum’s Filtek brand remains a global leader in dental restorative materials, holding an estimated 28% global market share in the $4.2bn restorative market (2024) in a slow-growing, mature category. These composites deliver gross margins near 62% and need far less promotional spend than digital dentistry tools, lowering opex. The 2025 launch of Solventum’s composite warmer lifted application speed by ~12% and improved retention rates by 3 points. This cash cow is being milked to fund the Transform for the Future restructuring program.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eTraditional Surgical Supplies\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eStandard hospital consumables—surgical instruments and drapes—are Solventum’s core Cash Cow in MedSurg, with global share ~18% and stable unit volumes in 2024–25. \u003c\/p\u003e\n\u003cp\u003eLow market growth (~2% CAGR) but Solventum’s 70‑year supply chain gives pricing power; these lines broke even in 2024 and drove +$120M of the company’s 2025 free cash flow uplift. \u003c\/p\u003e\n\u003cp\u003eThey need only maintenance capex (~$8M\/year) and routine procurement optimization to sustain high margins and cash generation. \u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eHealth Information Revenue Cycle Software\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eThe 360 Encompass platform contains mature billing modules acting as Cash Cows within Solventum’s BCG matrix, deeply embedded in hospital revenue cycles and delivering \u0026gt;90% client retention and recurring revenue with gross margins near 70% as of FY2025.\u003c\/p\u003e\n\u003cp\u003eCash flow from these modules funds R\u0026amp;D and go-to-market for the segment’s high-growth autonomous coding AI, supporting a balanced Health Information Systems portfolio and sustaining 20–25% incremental investment into AI initiatives in 2025.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eRetention \u0026gt;90%\u003c\/li\u003e\n\u003cli\u003eGross margin ≈70% (FY2025)\u003c\/li\u003e\n\u003cli\u003eRecurring revenue share high\u003c\/li\u003e\n\u003cli\u003e20–25% of cash reinvested into AI (2025)\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eLegacy Medical Tapes and Adhesives\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eSolventum’s Legacy Medical Tapes and Adhesives, spun off from 3M, remain market-leading cash cows with ~35% global share in clinical-grade tapes and steady 6% annual volume decline offset by 4% price mix, producing ~$420m EBITDA in 2025.\u003c\/p\u003e\n\u003cp\u003eThese products support daily clinical ops worldwide, need minimal marketing as industry standards, and funded debt cuts that halved leverage from 3.2x to 1.6x in 2025.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e~35% global market share\u003c\/li\u003e\n\u003cli\u003e$420m EBITDA (2025)\u003c\/li\u003e\n\u003cli\u003eLeverage cut 3.2x → 1.6x (2025)\u003c\/li\u003e\n\u003cli\u003eMinimal marketing, high margins\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eHigh‑margin Cash Cows: MedSurg, Filtek \u0026amp; 360 Encompass Deliver Strong FCF and EBITDA\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eCash Cows: MedSurg tapes\/IV kits (\u0026gt;40% share, $1.8bn market) generate ~$120M FCF, ~28% margins; Filtek composites (28% of $4.2bn market 2024) ~62% gross margin, funds Transform program; hospital consumables ~18% share, drove +$120M FCF uplift 2025; 360 Encompass billing modules \u0026gt;90% retention, ~70% gross margin; Legacy tapes ~35% share, $420M EBITDA 2025.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eProduct\u003c\/th\u003e\n\u003cth\u003eShare\u003c\/th\u003e\n\u003cth\u003eKey metric\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eMedSurg tapes\/kits\u003c\/td\u003e\n\u003ctd\u003e\u0026gt;40%\u003c\/td\u003e\n\u003ctd\u003e$120M FCF, 28% margin\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eFiltek composites\u003c\/td\u003e\n\u003ctd\u003e28%\u003c\/td\u003e\n\u003ctd\u003e62% GM\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eHospital consumables\u003c\/td\u003e\n\u003ctd\u003e18%\u003c\/td\u003e\n\u003ctd\u003e+$120M FCF uplift\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e360 Encompass\u003c\/td\u003e\n\u003ctd\u003e—\u003c\/td\u003e\n\u003ctd\u003e\u0026gt;90% retention, 70% GM\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eLegacy tapes\u003c\/td\u003e\n\u003ctd\u003e35%\u003c\/td\u003e\n\u003ctd\u003e$420M EBITDA\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003eWhat You See Is What You Get\u003c\/span\u003e\u003cbr\u003eSolventum BCG Matrix\u003c\/h2\u003e\n\u003cp\u003eThe file you're previewing is the exact Solventum BCG Matrix report you'll receive after purchase—no watermarks, no placeholders, just the fully formatted, analysis-ready document crafted for strategic clarity and stakeholder presentations.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"MatrixBCG","offers":[{"title":"Default Title","offer_id":56747951948153,"sku":"solventum-bcg-matrix","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0911\/3554\/1625\/files\/solventum-bcg-matrix.png?v=1772203201","url":"https:\/\/growthsharematrix.com\/products\/solventum-bcg-matrix","provider":"Growth Share Matrix","version":"1.0","type":"link"}